Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-01

Study Completion Date

2020-08-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The emergence of asymptomatic patients poses a significant challenge to the prevention and treatment of the epidemic.There have not been any treatment options that reduce the viral load or preventive options that reduce the risk of developing severe conditions.Therefore, present feasibility study of the safety and efficacy of Guduchi Ghan Vati was conducted in asymptomatic patients with COVID-19

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients

NCT04480398

Covid19 Asymptomatic Condition

COMPLETED

Community-based Post-exposure Prophylaxis for COVID-19

NCT04920773

Covid19

COMPLETED NA

A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19

NCT04621903

Covid19

COMPLETED NA

Ayurveda as Prophylaxis for Suspected COVID-19 Patients

NCT04395976

Covid-19

WITHDRAWN NA

Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak

NCT04345549

Flu Like Symptom Flu Like Illness

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ayurveda

Guduchi Ghana is a unique Ayuvedic classical preparation prepared from aqueous extracts of Tinospora cordifolia stem.

Group Type EXPERIMENTAL

Guduchi Ghan Vati

Intervention Type DRUG

Guduchi Ghan Vati was orally administered 2 tablets (1000 mg) twice daily for 2 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Guduchi Ghan Vati

Guduchi Ghan Vati was orally administered 2 tablets (1000 mg) twice daily for 2 weeks.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Giloya Amrita Tinosporia Cordifolus Guduchi

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All hospitalised cases above 18 years of age,
* Diagnosed with Covid-19
* Asymptomatic at the time of admission
* Agree to give consent

Exclusion Criteria

* Symptoms relating to Covid-19
* Severe vomiting
* Respiratory failure or requiring mechanical ventilation
* Patients having alanine transaminase (ALT) or aspartate transaminase (AST) \> 5 times the upper range of normal limits
* Patients with Covid-19 in critical condition or ARDS or NIAD 8 -point ordinal score-2
* Patients with uncontrolled diabetes mellitus
* Malignant,
* Chronic renal failure or
* On immunosuppressive medication

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No